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Background: Long-term follow up studies of functioning in people with bipolar (type I) and 
major depressive disorders (BD and MDD) have not been reported from    Africa. 
Objectives: To describe the long-term functional outcome of BD and MDD, and factors that 
influence such out- come. 
Methods: Door-to-door survey of 83,282 adults (ages 15–49 years) in a rural district of Ethiopia 
to identify potential cases whose diagnosis was later confirmed by standardized clinician 
interviews were followed by for an average of 11 years. The Short-Form- SF-36 scale was used 
to describe the functional outcome. Mixed linear models were used to evaluate potential factors 
associated with outcome. A total of 311 people with BD and 187 people with MDD that were 
identified at baseline and with complete data on functional outcome were included   in  the 
analyses. 
Results: Mean social functioning levels at baseline were 55–65% for people with BD and 55% 
for MDD but improved with follow-up. About 33% incident and 37% prevalent cases of people 
with BD had reduced social functioning for three years or more. Baseline functioning was 
significantly associated with longitudinal functioning. When baseline functioning is adjusted in 
the model, longitudinal functioning was not associated with socio-demographic or illness 
characteristics. 
Conclusions: The level of functions of people with BP and MDD were significantly lower than 
that of the general population both at baseline and during the follow-up period. Although there 
were improvements in function with follow-up, a significant proportion had functional deficits 






There has been a shift in mental health services from an emphasis on treatment focused on 
reducing symptoms to an approach which takes into consideration both well-being  and  
functioning  (Brazier  et   al., 2014). Bipolar disorder (BD) is the 16th leading cause of disability 
in the world responsible for the loss of more disability-adjusted life years than cancer, ischemic 
heart disease and major neurologic conditions (Ferrari et al., 2016), primarily because of its 
early onset and chronicity across the lifespan. Many long-term studies of functional outcome 
have been reported from developed countries (Dean, Gerner, & Gerner, 2004; Gitlin & 
Miklowitz, 2017; Goodwin, 2000). However, relatively few studies have been reported from 
developing countries (Brown et al., 1998; Dube, Kumar, & Dube, 1984; Khanna, Gupta, & 
Shanker, 1992; Rao & Nammalvar, 1977; Thomas, Nisha, & Varghese, 2016; Topuzoğlu et al., 
2015), and none from sub-Saharan   Africa. 
 
Major depressive disorder (MDD) is expected to be the leading cause of years of disability in 
2030 (Ferrari, Charlson, Norman, Patten, & Freedman, 2013). In addition to being a prevalent 
and chronic disorder, the level of functional impairment in MDD is as high as, or even higher 
than, chronic diseases, including cardiovascular disorders (Moussavi et al., 2007). The 
impairment continues even during remission from clinical symptoms (Verduijn et al., 2017). 
The functional outcome of MDD has been extensively studied in the developed world and to a 
lesser extent in developing countries as some recent reviews show (Sheehana, Nakagomeb, 
Asamic, Papadopoulos, & Boucher, 2017). However, because of the scarcity of long-term studies, 
the functional outcome of MDD in Africa is not known. 
 
We have earlier reported (Kebede et al., 2005; Kebede, Alem, Shibire Deyassa, Negash, & 
Beyero, 2006) the short-term functional outcome of BD from the Butajira follow up study of 
severe mental disorders that was initiated in 1998. The study was unique in that people with BP 
and MDD: (a) were recruited from a defined community instead of clinics, (b) had not had any 
medical treatment at baseline (over 97%), and (c) were followed for an average of 11 years to 
sufficiently allow assessment of long-term outcome. The present study de- scribes the long-term 







The details of the methods that were followed have been described elsewhere (Fekadu et al., 
2015; Kebede et al., 2003; Shibre et al., 2014; Shibre et al., 2015), but are briefly described here. 
The Butajira follow up study on severe mental disorders was initiated in 1998 with a door- to-
door survey of the district adult (ages 15–49 years) population estimated at 83,282. The 
psychoses and affective disorder modules of the Composite International Diagnostic Interview 
(CIDI) were used as a screening instrument to identify potential cases of severe mental dis- 
orders and was used to interview 68,378 individuals. The average non- response rate was more 
in rural areas (18.7%) than in the town (13.6%). Being out of the district on a business trip 
accounted for 65% of the non-response. In addition to the survey, key informants (KI) were 
used to identify individuals with probable severe mental illnesses. The performance of the CIDI 
and KI methods in identifying people with schizophrenia and affective disorders has been 
reported earlier (Shibre et al., 2002). 
 
In the second stage, those that tested positive for psychoses and affective disorders on the CIDI 
and those identified by key informants underwent evaluation by physicians using the Amharic 
version of the Schedule for Clinical Assessment in Neuropsychiatry (SCAN) (Wing, 1996; Wing 
et al., 1989). A total of 2166 individuals was identified as probable cases of schizophrenia or 
affective disorders by the CIDI interview. Of these, 1738 (80.5%) volunteered for the SCAN 
interview. The key informants identified a total of 719 probable cases of severe mental disorder. 
Of these, 547 (76.1%) subsequently underwent evaluation by the SCAN. A total of 2285 SCAN 
interviews was undertaken (79% of the total 2878 potential cases identified both by the CIDI 
interview and key informants). 
 
Out of the 2285 SCAN interviewed persons, 847 were diagnosed as having severe mental 
disorders (schizophrenia, BD or MDD) according to ICD-10 criteria. During the follow-up study, 
a total of 75 additional incident cases were diagnosed using the SCAN, bringing the total to 919. 
Of these, a total of 345 people with BD and 215 with MDD were identified initially. The present 
study focused on individuals with   BD (311)  and  MDD  (187)  with  complete  outcome  data  
which  met  the following inclusion criteria. (a) Age between 15 and 49 years; (b) re- sidence for 
at least six months in the area; and (c) evidence of the presence of BD (ICD-10 designation: F30, 
F31) and MDD (ICD-10 des- ignation: F32, F33) after a comprehensive assessment using the 
SCAN. People with bipolar II disorder were not included. 
 
People with severe mental disorders were scheduled for yearly follow-up evaluations after the 
baseline assessment, using the same instruments. Psychiatric nurses trained in its use 
administered the Short Form 36 (SF-36), which was used to quantify physical and social 
functional outcomes. The SF-36 is widely used for measuring outcomes of both physical and 
mental illnesses and has been shown to validly measure functioning and health-related quality 
of life (Brazier et al., 1992). The instrument has also demonstrated good internal consistency, 
stability, and concurrent validity in people with BD (Leidy, Palmer, Murray, Robb, & Revicki, 
1998). The Amharic version that was used in this study has also demonstrated good reliability 
and validity in the general population of Butajira (Kebede et al., 2004). The SF-36 instrument 
includes 36 items that yield eight domains (or scales) when scored. The physical functioning 
domain (PF, ten items) assesses limitations in physical activities, such as walking and climbing 
due to health problems. The social functioning domain (SF, two items) assesses limitation in 
social activities because of physical and emotional problems. Higher SF-36 scores represent 




Clinical course and outcome data were collected using the Longitudinal Interval Follow-up 
Evaluation (LIFE) chart (Keller et al., 1987). The LIFE chart is a semi-structured questionnaire 
suitable for summarizing longitudinal data. Four psychiatrists who were trained for four days 
administered the LIFE chart. The key rating tool in the LIFE chart is the Psychiatric Status 
Rating (PSR). The PSR is a six-point symptom severity rating, ranging from one to six. A rating of 
one indicates the absence of symptoms while a rating of six is consistent with severe symptoms. 
The PSR ratings were completed using all available information: reports by patients and family, 
the monthly clinical re- cords, annual symptomatic and functional ratings, reports from 
psychiatric nurses, and reports from the project outreach workers who had monthly contacts 
with the people with severe mental disorders and their families. When participants were unable 
to attend the psychiatric clinic for the final assessment, raters visited the person's house with 
their permission. 
 
We conducted a stratified analysis and presented the results of our study separately for 70 
incident cases of BP with the onset of re- cognizable illness within the last two years before 
recruitment into the study, and for 241 prevalent cases with onset of illness of three or more 
years. For MDD, 41 incident and 146 prevalent cases were analyzed, to describe the outcome in 
two different stages of illness, and also to limit the selection bias that could arise from the use of 
varying proportions of chronic  cases  (Eaton, 1995). 
 
A SAS-based SF-36 scoring algorithm (Ware, 1993) supplied by the developers of the 
instrument was used to calculate individual scores. IBM SPSS (version 19) was used for 
univariate, bivariate and multi- variate analyses. To evaluate potential predictors of outcome we 
employed linear random coefficient models. These models are superior to others in 
investigating individual change because they provide more flexibility in examining situations 
where there may be missing data and unequally spaced time intervals, which is the case with 
the present study (Heck, Thomas, & Tabata, 2011; Hennen, 2003). We fitted se- parate models 
for each of the two outcomes evaluated (yearly PF and SF scores) as dependent variables. As 
independent variables, the following were evaluated using the models. (a) sociodemographic 
characteristics: sex, age, marital status, literacy, urban-rural residence, religion; (b) illness 
characteristics: age of onset, speed of onset, duration of illness, history of medical treatment at 
baseline, medication adherence, and substance use; (c) year of follow-up; (d) annual PSR scores; 
and, (e) baseline SF and PF scores. Maximum likelihood estimations were used 
to fit the random coefficient models to the   data. 
 
The study was approved by the ethical review committees of both the Department of 
Community Health and the Faculty of Medicine, Addis Ababa University. The study has made 
possible the establishment of a mental health service in the district. The people identified with 
BD or MDD were offered psychiatric treatment as appropriate, free of charge and this has 







A total of 311 people with BD and 187 people with MDD that were identified at baseline and 
with complete data on functional outcome were included in the analyses. There were 70 
incident cases of BD and 41 incident cases of MDD (Fig. 1). For BD, the mean age was 29 years, 
and 46% were females, 65% were married, and 84% resided in rural areas. The mean duration 
of education was two years, and the group was followed for a mean of 11 years (Table 1). The 
corresponding figure for MDD is shown in Table 2. The mean age was 32 years, 62% were 
females, 71% were married, and 81% resided in rural areas. They were educated for a mean of 
two years and were followed for a mean of 11 years. 
Mean social functioning levels were low at baseline for both people with BD (55–65%) and MDD 
(55%) but improved with follow-up. In both BD and MDD, there were progressive increase in 
the SF-36 social functioning (SF) scores (i.e., the trend of improvement) for most of the follow-
up period (Figs. 2 and 3). The level and pattern of improvement were similar between the 
incident and prevalent cases. However, the scores for both incident and prevalent cases were 
lower than the po- pulation means for most of the follow-up period. This gap was statis- tically 
significant until the 6th year of follow-up. Beyond this year there was an overlap of the 95% 
confidence limits of the mean values be- tween the study and the general population. There was 
no marked improvement in the progression of physical function (PF) scores, nor any significant 
gap between the PF scores of the cohort and the general population. 
A third of incident (33%) and prevalent cases (37%) of BD had re- duced social functioning for 
three years or more (Fig. 3). The corre- sponding percentages for physical function were 17% 
for the incident and 28% for prevalent cases. For MDD about half of the incident (46%) and 
prevalent (49%) cases had reduced social function for three years or more (Fig. 4). About one-
fifth of incident cases and 35% of prevalent cases of MDD had reduced physical function for 
three years or more (Fig. 5). 
The trend in the improvement of the social functioning of people with BD during the follow-up 
period was statistically significant   (P < 0.001) for both incident and prevalent cases (Table 3). 
The trend in the improvements of the physical functioning of the incident and prevalent cases 
were also statistically significant (P < 0.001, not shown in the Table). SF scores increased 
significantly in the incident (P = 0.001) and prevalent (P < 0.001) cases of MDD (Table 4). The 
increase in PF scores was not statistically significant (not shown) (Fig. 5). 
Baseline levels of social functioning of people with BD were sig- nificantly associated with 
improving trend of social functioning during the follow-up period in both incident and prevalent 
cases (P < 0.001). Both follow-up PSR (i.e., symptom severity) scores for mania and de- pression 
were not significantly associated with improvement in social functioning. Sex, religion, rural 
residence, the age of onset, the speed of onset, duration of illness, history of use of neuroleptic 
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treatment before recruitment, and substance use (alcohol, tobacco, and khat1) were not 
associated with social functioning. Similarly, baseline physical func- tioning was significantly 
associated with improving trend of physical functioning during the follow-up period. None of 
the other factors included were significantly associated with improvement of physical 
functioning (not shown). 
Baseline levels of social functioning were significantly associated  (P < 0.001) with improving 
trend of social functioning of both in- cident and prevalent cases of MDD during the follow-up  
period  (Table 4). The association between follow-up PSR scores and im- provement in social 
functioning were not significant. None of the de- mographic or illness characteristics included in 
the model were sig- nificantly associated with improvement of social functioning. A similar 
pattern of significant association  of  follow-up  PF  with  baseline  PF (P < 0.001) was observed, 
but this was not the case for follow-up PSR or any of the demographic or illness characteristics 
included in the model (not shown). 
 
  
                                                             
1 Khat is a flowering plant (Catha edulis), the leaves of which are chewed for their stimulant and appetite-
suppressing effect. The leaves contain cathinone, 





The results show poor social and, to a lesser extent, physical functioning at baseline, that 
improved with follow-up of people with BD and MDD. However, the level of functioning of a 
third of the people with BD and half of the people with MDD was below the norm for the general 
population for most of the follow-up period. Baseline functioning was a predictor of long-term 
functioning in both BD and MDD. When baseline functioning was adjusted for, the long-term 
functioning of either the people with BD nor MDD was associated with several socio-demo- 
graphic and illness characteristics. 
 
We have attempted to limit the influence of several potential con- founders, selection bias and 
other methodological problems that af- fected several other outcome studies (Keck et al., 1998; 
MacQueen, Young, & Joffe, 2001). Specifically, the participants were recruited from a defined 
community, they were predominantly (93%) neuroleptic naive at baseline (Negash et al., 2005), 
and were followed over an extended period to assess long-term outcome. We have employed 
widely acceptable and standardized diagnostic classification methods and data collection tools 
to identify and classify cases and to measure both outcomes and potential predictors (Eaton, 
1995). We have also stratified our analysis by the incident and prevalent cases to limit se- 
lection bias and used random mixed linear models to adjust for potential confounders in 
assessing predictors of functional outcome (Hennen,  2003). 
 
Social functioning was markedly lower than that of the general population in both BD and MDD 
at baseline and at all subsequent years of follow-up indicating a high level of residual disability. 
We have as- sumed that the level of functioning of the general population remained constant 
during the follow-up period. Although variation in the level of functioning of the general 
population is to be expected, it is unlikely that any variation will be large. Very few studies had 
compared their cases’ long-term functioning with that of the general population. Gutierrez-
Rojas et al. (2008) and ten Doesschate, Koeter, Bockting, Schene, and The DELTA Study Group 
(2010) have shown that func- tioning of people with BD and recurrent MDD were markedly 
lower than that of the population norm. A comparison of people with and without BD and MDD 
has also shown similar results during a 3-year follow-up in another study (Rhebergen et al., 
2010). A review of studies on BD (MacQueen et al., 2001) has shown that 30–60% had 
detectable levels of psychosocial impairment during follow-up. Our findings also lie within these 
ranges. 
 
We have also shown that a substantial proportion of people with BD (about a third) and MDD 
(about half) had reduced function for three years or more, showing the chronicity of both 
disorders. Other studies have reported that the proportion of time impaired between 30% and 
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40% as reviewed by Sanchez-Moreno et al. (2009). The NIMH Collaborative Depression Study 
has also reported 54 to 59% of follow-up time impaired in people with BD and MDD followed 
for an average of 18 years (Judd et al., 2008). Analysis of pooled data from 25 studies   of 
3936 people with BD and 6415 with MDD followed for over nine years has shown that the 
proportions of time spent in illness were 44% for BD and 46% for MDD (Forte et al.,    2015). 
None of the socio-demographic factors considered in the present study were significantly 
associated with improved functioning in either people with BD or MDD. Comparison of our 
findings with what has been reported in the literature may be difficult because of 
methodological differences. However, our results are in accordance with the results of a recent 
systematic review and meta-analysis (Bortolato et al., 2017),   which   reported   that   13   
demographic   factors    (Education, education of parents, ethnicity, gender, income, marital 
status, occupation, place of residence, SES, unemployment), and medication and substance use 
were not associated with functional outcome in people with BD. 
 
None of the clinical characteristics considered in our study (age of onset, the speed of onset, 
duration of illness at entry, neuroleptic use at entry, substance use, or follow-up symptom 
severity score), were associated with functional outcome. Age of onset, duration of illness and 
type of onset may not be reported accurately in a population of low mental health literacy. Our 
report of the lack of significant association of improved functional outcome with the duration of 
illness and history of medical treatment at baseline may not correspond to reports of other 
studies (Altamura et al., 2011; Medeiros et al., 2016Medeiros, Senco, Lafer, & Almeida, 2016; 
Vieta et al., 2018). Again, comparison of our findings with what has been reported in the 
literature may be difficult because of methodological differences. 
 
As was the case in the present study, depressive symptoms were not associated with functional 
outcome when adjusted for demographic and clinical characteristics, in the Systematic 
Treatment Enhancement Program for BD (STEP-BD) Study (Zhang et al., 2006). However, other 
studies had shown such relationship as reviewed by (Gitlin & Miklowitz, 2017), which showed a 
large percentage of cases continued to have lower functioning even when they were not 
symptomatic, and the poor functioning in BD was due more to depressive symptoms than 
mania. It is not clear whether such associations persist on the long-term as almost all of these 
studies were cross-sectional or short-term (Kennedy, Foy, Sherazi, McDonough, & McKeon, 
2007) and did not adjust for baseline functioning in their analyses as we did. Most of the effect 
of symptom severity could be early in the follow-up period as was the case in the present study. 
In our earlier study of short-term functioning (Fekadu et al., 2006; Kebede et al., 2006) 
symptoms were significantly associated with functional outcome in the short-term. Our study, 
however, examined the role of symptom severity on functional improvement during follow-up 
for an average of 11 years. It is also possible that discrimination, which was not measured in the 
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present study, was associated with functional outcome, independent of symptom   severity   –   
for   example   those   that   have   achieved full symptomatic recovery may have difficulty getting 
a job or getting married because of their previous behavior when symptomatic (Habtamu, Alem, 
& Hanlon,  2015). 
 
There are some limitations to this study. One of the limitations of the study is that the 
prevalence of MDD reported in the current study is lower than expected from the literature, 
including our previous report (Kebede & Alem, 1999) of the prevalence of 3.4% in females and 
1.4% in males. In their systematic review of global variations of the pre- valence of MDD, 
Ferrari, Somerville, et al. (2013), had reported a global average of 4.7%. The reason for the 
lower prevalence of MDD in our study, and whether this sample is an unbiased selection, is thus 
not clear. It is possible that cases of MD with psychotic features were over- represented in the 
sample because the identification and recruitment of cases of MDD were done together with 
that of schizophrenia and BD. The psychotic features of the latter two diagnoses and our use of 
key informants to identify cases from the community may have resulted in a preferential 
selection of cases MDD with psychotic features, although we cannot confirm this given the 
present data. We have not assessed cognitive deficits, which have been shown to be strongly 
associated with functioning (Gitlin & Miklowitz, 2017). We were not able to do more frequent 
assessments of functional outcomes for logistic reasons, and thus, cannot ascertain whether our 
yearly outcome assessments truly reflect the pattern of outcome for the whole 12 months 
between assessment. 
 
In conclusion, our study shows that the levels of functioning of both people with BD and MDD 
were significantly lower than that of the general population at baseline and follow-up. Although 
there were improvements in function with follow-up, between  a third  of people with BD and 
half of MDD cases had functional deficits in the long-term. When baseline functioning was 
controlled for, none of the demographic or clinical characteristics of cases were associated with 
longitudinal functioning. 
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 Table 1: Baseline characteristics of people with bipolar disorder in the Butajira follow-up 
study, Ethiopia 
* Incident cases are those with the onset of illness two years or less on entry to the study.  **Acute = onset within 
three months or less.  ***Missing values not shown. Sub-totals may vary. ****Higher mean score values indicate 
higher functioning. ****Higher mean score values indicate more severe symptoms. 
  
  Incident Cases* Prevalent Cases All Cases 
  Number Percent Number Percent Number Percent 
Sex Female 
30 42.9 113 46.9 143 46.0 
 Male 40 57.1 128 53.1 168 54.0   
      
Religion Muslim 
52 74.3 164 68.0 216 69.5  
Christian 18 25.7 77 32.0 95 30.5   
      
Marital status Married 32 45.7 168 70.3 200 64.7  
Others 
38 54.3 71 29.7 109 35.3 
        
Residence Urban 8 11.4 42 17.4 50 16.1  
Rural 62 88.6 199 82.6 261 83.9 
        
Speed of onset Acute** 60 85.7 206 95.4 262 94.9 
 Insidious 10 14.3 10 4.6 14 5.1 
        
History of medical 
treatment at baseline 
None 
58 98.3 195 97.5 253 97.7 
 Other 1 1.7 5 2.5 6 2.3 
        
Medication adherence 75% or less 
53 76.8 146 60.6 199 64.2 
 >75% 
16 23.2 95 39.4 111 35.8 
        
Substance use No 
62 88.6 214 88.8 276 88.7  
Yes 8 11.4 27 11.2 35 11.3 
Total***  70 100.0 241 100.0 311 100.0 
        
  Mean Standard 
Error (SE) 
Mean SE Mean SE 
Age Years 24.2 .9 30.5 .5 29.1 .5 
         
Education Years 
1.9 .4 2.2 .2 2.1 .2 
        
Age of onset Years 
23.1 .9 21.3 .4 21.7 .4 
        
Duration of illness at 
entry to study 
Years 
2.0 .8 9.6 .5 7.9 .4 
        
Follow-up duration Years 
10.4 .3 10.9 .2 10.8 .1 




82.1 2.3 79.1 1.2 79.8 1.0 
  




63.9 3.2 58.5 1.5 59.7 1.3 




3.2 .3 2.2 .1 2.5 .1 
19 
 
Table 2: Baseline characteristics of the people with major depressive disorder in the Butajira 
follow-up study, Ethiopia 
* Incident cases are those with the onset of illness two years or less on entry to the study.  **Acute = onset within 
three months or less.  ***Missing values not shown. Sub-totals may vary. ****Higher mean score values indicate 
higher functioning. ****Higher mean score values indicate more severe symptoms. 
  Incident Cases* Prevalent Cases All Cases 
  Number Percent Number Percent Number Percent 
Sex Female 22 53.7 93 63.7 115 61.5 
 Male 
19 46.3 53 36.3 72 38.5   
      
Religion Muslim 
30 73.2 97 66.4 127 67.9  
Christian 11 26.8 49 33.6 60 32.1   
      
Marital status Married 24 60.0 106 73.6 130 70.7  
Others 
16 40.0 38 26.4 54 29.3 
        
Residence Urban 
12 29.3 24 16.4 36 19.3  
Rural 29 70.7 122 83.6 151 80.7 
        
Speed of onset** Acute 27 81.8 120 88.2 147 87.0 
 Insidious 6 18.2 16 11.8 22 13.0 
        
History of medical 
treatment at baseline 
None 
34 97.1 135 98.5 169 98.3 
 Other 1 2.9 2 1.5 3 1.7 
        
Medication adherence 75% or less 
29 70.7 11 57.9 138 73.8 
 >75% 
12 29.3 8 42.1 49 26.2 
        
Substance use No 
40 97.6 137 93.8 177 94.7  
Yes 1 2.4 9 6.2 10 5.3 
Total***  41 100.0 146 100.0 187 100.0 
        
  Mean Standard 
Error (SE) 
Mean SE Mean SE 
Age Years 28.7 1.4 33.1 .7 32.1 .7 
         
Education Years 2.5 .5 1.9 .3 2.1 .3 
        
Age of onset Years 
27.7 1.5 26.5 .7 26.8 .6 
        
Duration of illness at 
entry to study 
Years 
1.1 .1 8.1 .7 6.5 .6 
        
Follow-up duration Years 
10.5 .4 11.1 .2 11.0 .2 




79.9 3.6 77.7 1.5 78.2 1.4 
  




56.1 3.2 57.8 1.9 57.4 1.6 











Bipolar disorder: 311  
Schizophrenia: 359 
 
Major depression: 215 
Screened at baseline (using CIDI): 68,378 (82%) 
Population of Butajira District aged 15-49 years: 83,282 
 
Screened positive by CIDI: 2,166 
Identified by key informants: 719 
Interviewed using SCAN: 2,285 
SCAN diagnosed cases at baseline: 847 
Not included because if 
incomplete outcome (SF36)  
data: 28 
Incident cases: 70 Prevalent Cases: 241 
Bipolar disorder: 345 
 
Incident cases during study period: 75 
SCAN diagnosed cases at baseline: 919 
Not included because 
of incomplete outcome 
(SF36) data: 34 Major depression: 187 
Incident cases: 41 Prevalent Cases: 146 




 Figure 1 Yearly trend in mean functioning level (%) of people with bipolar disorder* compared to the general population norm, Butajira, Ethiopia (the fine dotted 
lines represent 95% confidence limits)  
 
* Incident cases (n=70) are those with the onset of illness two years or less on entry to the study. The rest were categorized as prevalent cases (n=241); Short Form 
Medical Outcome (SF-36) physical and social function scores were used as outcome measures. SF-36 score mean values are given on a scale of 1 to 100. Higher 





Figure 3 Yearly trend in mean functioning level (%) of people with major depressive disorder* compared to the general population norm, Butajira, Ethiopia (the 
fine dotted lines represent 95% confidence limits) 
 
* Incident cases (n=41) are those with the onset of illness two years or less on entry to the study. The rest were categorized as prevalent cases (n=146); Short Form 
Medical Outcome (SF-36) physical and social function scores were used as outcome measures. SF-36 score mean values are given on a scale of 1 to 100. Higher 






Figure 4 Length of time in which people with bipolar disorder had reduced social and physical functioning*, Butajira, Ethiopia 
 
* As compared with the population norm. For example: about a third (28%) of prevalent and one-fifth (21%) of incident cases had reduced social functioning for four years or 




Figure 5 Length of time in which people with major depressive disorder had reduced social and physical functioning*, Butajira, Ethiopia 
 
 
* Short Form Medical Outcome (SF-36) physical and social function scores were used as outcome measures. For example: about a third of incident (32%) and of prevalent 





Table 3 Factors associated with long-term (11-year) social functioning of people with bipolar disorder in Butajira, Ethiopia 
  Incident Cases*  Prevalent Cases  All Cases 
  B** 95% confidence 
interval 
  B** 95% confidence 
interval 
  B** 95% confidence 
interval 
 
   Lower Upper P   Lower Upper P   Lower Upper P 
Age  Years -.05 -.2 .1 ns  .01 -.04 .1 ns  .003 -.04 .04 ns 
Sex Female .2 -1.4 1.7 ns  .3 -.4 1.1 ns  .3 -.4 .9 ns 
 Male Ref     Ref     Ref    
Residence Urban  .3 -2.4 2.9   .01 -1.0 1.0   .1 -.9 1.0  
  Other Ref   ns  Ref   ns  Ref   ns 
Education Years -.05 -.4 .3   -.1 -.2 .1   -.1 -.2 .1  
                
Religion  Muslim .9 -1.2 2.9 ns  -.7 -1.5 .1 ns  -.6 -1.3 .2 ns 
 Other Ref     Ref     Ref    
Marital status Married .4 -1.8 2.6 ns  -.6 -1.5 .3 ns  -.5 -1.3 .3 ns 
 Other Ref     Ref     Ref    
Age of onset Years -.1 -1.2 .9   .01 -.1 .1   -.001 -.1 .1  
     ns     ns     ns 
Speed of onset Acute -.3 -3.6 3.0   .02 -2.0 2.0   .1 -1.6 1.8  
 Insidious Ref     Ref     Ref    
Duration of illness at entry Years .02 -.2 .2 ns  .01 -.1 .1 ns  .01 -.04 .1 ns 
                
Baseline history of treatment No 2.8 -1.2 6.8 ns  1.0 -1.5 3.5 ns  1.4 -.7 3.5 ns 
 Yes Ref              
                
Medication adherence <75% .3 -1.6 2.2 ns  -.5 -1.2 .2 ns  -.4 -1.1 .2 ns 
 >75% Ref              
     ns     ns     ns 
Substance use No -1.0 -3.2 1.1   .5 -.8 1.7   .1 -.9 1.2  
 Yes Ref     Ref     Ref    
Follow-up mania symptom 
severity score  
1-6 
.03 -.9 1.0 ns 
 
-.1 -.6 .4 ns 
 
-.04 -.5 .4 ns 
Follow-up depression symptom 
severity score 
1-6 
.1 -1.1 1.3 ns 
 
.1 -.3 .5 ns 
 
.1 -.3 .5 ns 
Baseline social function score 1-100 .4 .3 .5 <.001  .5 .4 .5 <.001  .5 .4 .5 <.001 
Time  Years 1.5 .7 2.3 <.001  1.6 1.2 2.0 <.001  1.6 1.2 1.9 <.001 
Intercept  1-100 74.3 69.8 78.7 <.001  72.7 70.6 74.9 <.001  73.1 71.1 75.0 <.001 
* Incident cases are those with the onset of illness two years or less on recruitment to the study. **Yearly follow-up mean scores on the Short Form Medical Outcome (SF-36) social function scores were 
used as outcome measures. Coefficients, B, obtained from a random coefficient model adjusted for age, sex, baseline SF36 scores, longitudinal PSR scores, and follow-up duration. A positive coefficient, B, 




Table 4 Factors associated with long-term (11-year) social functioning of people with major depressive disorder in Butajira, Ethiopia 
  Incident Cases*  Prevalent Cases  All Cases 
  B** 95% confidence 
interval 
  B** 95% confidence 
interval 
  B** 95% confidence interval  
   Lower Upper P   Lower Upper P   Lower Upper P 
Age  Years -.02 -.1 .1 ns  .02 -.03 .1 ns  .01 -.03 .1 ns 
Sex Female -.2 -2.2 1.7 ns  .4 -.6 1.3 ns  .2 -.6 1.1 ns 
 Male Ref     Ref     Ref    
                
Residence Urban  2.0 -.4 4.4 ns  1.1 -.1 2.4 ns  1.3 .2 2.4 ns 
  Other Ref     Ref     Ref    
                
Education Years .4 -.004 .8 ns  .1 -.2 .3 ns  .2 -.01 .4 ns 
                
Religion  Muslim -1.5 -3.8 .8 ns  -.1 -1.0 .9 ns  -.3 -1.2 .6 ns 
 Other Ref     Ref     Ref    
                
Marital status Married .2 -1.8 2.2 ns  .8 -.4 1.9 ns  .7 -.3 1.7 ns 
 Other Ref     Ref     Ref    
                
Age of onset Years .3 -1.0 1.6 ns  .01 -.1 .1 ns  -.001 -.1 .1 ns 
                
Speed of onset Acute .9 -1.6 3.4 ns  -.2 -1.5 1.2 ns  -.1 -1.3 1.0 ns 
 Insidious Ref     Ref     Ref    
                
Duration of illness at entry Years -.2 -1.4 1.1 ns  .1 -.002 .1 ns  .1 .001 .1 ns 
                
Baseline history of treatment No -2.3 -7.0 2.4 ns  -1.9 -5.9 2.1 ns  -2.1 -5.0 .8 ns 
 Yes Ref     Ref     Ref    
                
Medication adherence <75%  -1.4 -3.8 .9 ns  .8 -.1 1.8 ns  .4 -.4 1.3 ns 
 >75% Ref              
                
Substance use No -3.7 -8.7 1.4 ns  -1.9 -4.1 .2 ns  -2.2 -4.1 -.2 ns 
 Yes Ref     Ref     Ref    
Follow-up symptom severity score 1-6 .2 -.6 1.0 ns  .2 -.2 .7 ns  .1 -.3 .5 ns 
Baseline social function score 1-100 .6 .4 .8 <.001  .5 .4 .6 <.001  .5 .5 .6 <.001 
Time  Years 1.8 .7 2.9 .001  1.9 1.3 2.4 <.001  1.9 1.4 2.4 <.001 
Intercept  1-100 68.9 63.5 74.4 <.001  68.2 65.2 71.2 <.001  68.4 65.8 71.0 <.001 
* Incident cases are those with the onset of illness two years or less on recruitment to the study. **Yearly follow-up mean scores on the Short Form Medical Outcome (SF-36) social function scores were 
used as outcome measures. Coefficients, B, obtained from a random coefficient model adjusted for age, sex, baseline SF36 scores, longitudinal PSR scores, and follow-up duration. A positive coefficient, B, 
indicates a trend of improvement in functioning. ns=not significant 
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